Vivani Medical, Inc.
VANI
$-0.01
Change (1 day)
$7.80
Year High
$0.84
Year Low
Categories
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
P/E ratio for Vivani Medical, Inc. (VANI)
P/E ratio as of 2023: -2.02
According to Vivani Medical, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.02. At the end of 2022 the company had a P/E ratio of -4.97.
P/E ratio history for Vivani Medical, Inc. from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -2.02 |
| 2022 | -4.97 |
| 2021 | -4.45 |
| 2020 | -4.15 |
| 2019 | -2.60 |
| 2018 | -1.67 |
| 2017 | -3.63 |
| 2016 | -2.35 |
| 2015 | -10.49 |
| 2014 | -23.88 |
| 2013 | -98.43 |
| 2012 | -138.89 |